Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
InMed Pharmaceuticals Inc. (INM) had Return on Equity of -1057.94% for the most recently reported fiscal year, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-12.99M |
|
-- |
|
-- |
|
$11.35M |
|
$-11.35M |
|
$-0.02M |
|
$-11.37M |
|
$-11.18M |
|
$-11.37M |
|
$-11.37M |
|
$-12.56M |
|
$-11.18M |
|
$-11.35M |
|
$-11.15M |
|
4.16M |
|
4.16M |
|
$-3.12 |
|
$-3.12 |
|
| Balance Sheet Financials | |
$2.68M |
|
$0.22M |
|
$0.35M |
|
$3.03M |
|
$1.96M |
|
-- |
|
-- |
|
$1.96M |
|
$1.07M |
|
$1.07M |
|
$1.07M |
|
5.34M |
|
| Cash Flow Statement Financials | |
$-8.64M |
|
-- |
|
$0.09M |
|
$10.74M |
|
$2.19M |
|
$-8.55M |
|
$0.11M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.37 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-8.64M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Return on Equity |
-1057.94% |
-1057.96% |
|
-375.34% |
|
-1057.96% |
|
$0.20 |
|
$-2.08 |
|
$-2.08 |
|